Variations in the frequency of MRSA infections across acute NHS hospitals, Paul Fenn Dev Vencappa Alastair Gray Oliver Rivero Neil Rickman
Background This study originated as part of research on the relationship between liability risk-sharing measures and patient safety in the NHS [funded under the ESRC Public Services Programme] Data on risk sharing measures available from the NHS Litigation Authority Discounts available for risk management standards; hypothesis – financial incentives improve (or signal) patient safety measures, including hospital hygeine MRSA surveillance data collected by Health Protection Agency since 2001 has progressively extended the panel of data that can be analysed alongside other DoH administrative datasets Permits a wider set of hypotheses to be tested using panel data estimation methods in relation to the factors driving MRSA infection rates across hospitals and over time Changes in length of stay, casemix and bed utilisation could plausibly affect the rate of hospital infections
Trends
Staphylococcus aureus bacteraemia reports (HPA, 2007)
MRSA bacteraemia reports from 2001 to 2006
MRSA infection rates by HC region from 2001 to 2006
Mean length of stay by HC region from 2001 to 2006
Mean bed utilisation rates by HC region from 2001 to 2006
Distributions
Distributions of MRSA infections, NHS Acute Trusts Source: MRSA Surveillance System, Department of Health
Distributions of MRSA infection rates by HC region
Drivers
Activity levels and casemix Source: Hospital Episode Statistics by specialty, Department of Health
Direct measures to control MRSA, : CMO provides specific directions on actions that should be taken to reduce healthcare associated infections: better surveillance, improved techniques for use of catheters, tubes and instruments, higher standards of hygiene in clinical practice, more prudent use of antibiotics, and a range of managerial and organisational changes 2004: CleanYourHands campaign launched by the NPSA 2004: DoH directs additional resources towards NHS trusts with particularly high MRSA rates 2006: new Health Act introduced detailed hygiene code for NHS organisations to assess and manage infection risks, implement clinical care protocols, and provide training 2007: Deep Clean initiative launched by DoH
CNST risk management standards, CNST discount: 0% 10% 20% 30% Source: NHS Litigation Authority
Standard Criterion Governance Competent & Capable Workforce Safe Environment Clinical Care Learning from Experience 1Risk management strategy Corporate inductionSecure environmentPatient identificationIncident reporting 2Policy on procedural documents LocalLocal induction of permanent staff permanent staff Child protectionPatient informationRaising concerns 3Risk management committee(s) LocalLocal induction of temporary staff Vulnerable adultsConsentComplaints 4Risk awareness training for senior management Supervision of medical staffSupervision of medical staff in training Moving & handlingClinical record-keeping standards Claims 5Risk management process Risk management training Slips, trips & fallsTransferTransfer of patientsInvestigations 6Risk registerTraining needs analysis Inoculation incidentsMedicines management Analysis 7Responding to external recommendations specific to the organisation Medical devices training Maintenance of medical devices & equipment Blood transfusionImprovement 8Clinical records management Hand hygiene trainingHarassment & bullyingResuscitationBest practice - NICE, NCEs & national guidance 9Professional clinical registration Moving & handling training Violence & aggressionInfection controlBest practice - NSFs & high level enquiries high level enquiries 10Employment checksSupporting staff involved in an incident, complaint or claim StressDischargeDischarge of patientsBeing open Source: NHSLA April 2007
Estimation
Estimating equation
Estimation Issues Zero observations [x it = 0] Some hospitals omitted from analysis Solution: assume count data process and estimate using QMLE or MLE
Estimation Issues Clustered sampling [ it is not iid in pooled regression] Can lead to over-acceptance of hypotheses relating to β 1 and β 2 Solution: use cluster-robust standard errors
Estimation Issues Unobserved heterogeneity [u i 0] Omitted variable bias and/or inefficiency if hospital effects unmodelled Solution: use panel data estimation methods (random effects; fixed effects; first differencing)
Estimation Issues Endogeneity [E(d it v it ) 0] Simultaneity bias Solution: use IV or GMM estimation methods Internal instruments: lagged values of d it External instruments: claims experience of hospital
Results
Estimation with exogenous regressors Note: Region and year dummies omitted
Estimation with exogenous regressors Note: Region and year dummies omitted
Estimation with exogenous regressors Note: Region and year dummies omitted
Estimation with exogenous regressors Note: Region and year dummies omitted
Estimation with exogenous regressors Note: Region and year dummies omitted
Estimation with endogenous regressors Note: Region and year dummies omitted
Unexplained reduction in MRSA rate relative to 2001
Conclusions
Average length of stay is the main driver behind changes in MRSA infection rates over time Of the 27% fall in MRSA rates between 2001/2 and 2006/7, somewhere between 11% (short-run) and 19% (long-run) is attributable to the overall fall in length of stay over this period Because the other factors we explored are either insignificant or have changed little over the period, the remaining fall in the MRSA rate is unexplained and could potentially be attributable to measures such as the NPSAs CleanYourHands campaign Casemix and location are important factors explaining differences in MRSA rates across acute hospitals Hospitals with a higher proportion of surgical admissions have higher MRSA rates; hospitals with a higher proportion of O&G, paediatric, and psychiatric admissions have lower MRSA rates. Acute hospitals in London, the South-East and the West Midlands have significantly higher MRSA rates than in other regions, after controlling for other factors including casemix and length of stay
Conclusions Controlling for casemix, location and length of stay, single- specialty acute hospitals have much lower MRSA rates than other acute hospitals Controlling for casemix, location and length of stay, acute teaching hospitals have higher MRSA rates than other acute hospitals (although this differential has weakened considerably since 2003) There is some (inconclusive) evidence that hospitals achieving the highest CNST risk management standard (level 3) have lower MRSA infection rates There is no evidence that, after controlling for location, variations in bed utilisation rates across acute hospitals have a significant effect on their MRSA infection rates